Cabaletta Bio, Inc. (CABA) Tops Q2 EPS by 8c

Cabaletta Bio, Inc. (NASDAQ: CABA) reported Q2 EPS of ($0.45), $0.08 better than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Cabaletta Bio, Inc. (CABA) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• William Blair Starts Yesway Inc (YSWY) at Outperform
• William Blair Downgrades Endava PLC (ADR) (DAVA) to Underperform